These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25264075)

  • 41. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solubilized phenyl-pyrazole ureas as potent, selective 5-HT(2A) inverse-agonists and their application as antiplatelet agents.
    Dosa PI; Strah-Pleynet S; Jayakumar H; Casper M; Decaire M; Xiong Y; Lehmann J; Choi K; Elwell K; Wong A; Webb RR; Adams JW; Ramirez J; Richman JG; Thomsen W; Semple G; Teegarden BR
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5486-9. PubMed ID: 19665894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced selectivity profile of pyrazole-urea based DFG-out p38alpha inhibitors.
    Liu H; Kuhn C; Feru F; Jacques SL; Deshmukh GD; Ye P; Rennie GR; Johnson T; Kazmirski S; Low S; Coli R; Ding YH; Cheng AC; Tecle H; English JM; Stanton R; Wu JC
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4885-91. PubMed ID: 20620059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design and discovery of 2-(4-(1H-tetrazol-5-yl)-1H-pyrazol-1-yl)-4-(4-phenyl)thiazole derivatives as cardiotonic agents via inhibition of PDE3.
    Duan LM; Yu HY; Li YL; Jia CJ
    Bioorg Med Chem; 2015 Sep; 23(18):6111-7. PubMed ID: 26319621
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The discovery of potent selective NPY Y(2) antagonists.
    Chai W; Wong VD; Nepomuceno D; Bonaventure P; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4141-4. PubMed ID: 23756063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists.
    Kalla RV; Elzein E; Perry T; Li X; Palle V; Varkhedkar V; Gimbel A; Maa T; Zeng D; Zablocki J
    J Med Chem; 2006 Jun; 49(12):3682-92. PubMed ID: 16759111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists.
    Pennell AM; Aggen JB; Sen S; Chen W; Xu Y; Sullivan E; Li L; Greenman K; Charvat T; Hansen D; Dairaghi DJ; Wright JJ; Zhang P
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1228-31. PubMed ID: 23374868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The structures of two scorpionates: thallium tetrakis(3-phenyl-1H-pyrazol-1-yl)borate and potassium tetrakis(3-cyclopropyl-1H-pyrazol-1-yl)borate.
    Infantes L; Claramunt RM; Sanz D; Alkorta I; Elguero J
    Acta Crystallogr C Struct Chem; 2016 Nov; 72(Pt 11):819-825. PubMed ID: 27811418
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist.
    Qiao JX; Wang TC; Ruel R; Thibeault C; L'Heureux A; Schumacher WA; Spronk SA; Hiebert S; Bouthillier G; Lloyd J; Pi Z; Schnur DM; Abell LM; Hua J; Price LA; Liu E; Wu Q; Steinbacher TE; Bostwick JS; Chang M; Zheng J; Gao Q; Ma B; McDonnell PA; Huang CS; Rehfuss R; Wexler RR; Lam PY
    J Med Chem; 2013 Nov; 56(22):9275-95. PubMed ID: 24164581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Discovery of N-(1-(2-hydroxyethyl)quinolin-2-one)-N'-(1-phenyl-1H-pyrazol-5-yl)methyl) urea as Mode-Selective TRPV1 antagonist.
    Zuo D; Hong M; Jung A; Lee S; Do N; Jung S; Jeon Y; Won Jeong J; Huang G; Li LX; Blumberg PM; Yoon H; Lee Y; Ann J; Lee J
    Bioorg Med Chem Lett; 2024 Mar; 101():129656. PubMed ID: 38355061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of a series of 2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)acetamides as novel molecular switches that modulate modes of K(v)7.2 (KCNQ2) channel pharmacology: identification of (S)-2-phenyl-N-(2-(pyrrolidin-1-yl)phenyl)butanamide (ML252) as a potent, brain penetrant K(v)7.2 channel inhibitor.
    Cheung YY; Yu H; Xu K; Zou B; Wu M; McManus OB; Li M; Lindsley CW; Hopkins CR
    J Med Chem; 2012 Aug; 55(15):6975-9. PubMed ID: 22793372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pyrazolyl-Ureas as Interesting Scaffold in Medicinal Chemistry.
    Brullo C; Rapetti F; Bruno O
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic α
    Procopiou PA; Anderson NA; Barrett J; Barrett TN; Crawford MHJ; Fallon BJ; Hancock AP; Le J; Lemma S; Marshall RP; Morrell J; Pritchard JM; Rowedder JE; Saklatvala P; Slack RJ; Sollis SL; Suckling CJ; Thorp LR; Vitulli G; Macdonald SJF
    J Med Chem; 2018 Sep; 61(18):8417-8443. PubMed ID: 30215258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pyrazole derivatives as selective orexin-2 receptor antagonists (2-SORA): synthesis, structure-activity-relationship, and sleep-promoting properties in rats.
    Brotschi C; Bolli MH; Gatfield J; Roch C; Sifferlen T; Treiber A; Williams JT; Boss C
    RSC Med Chem; 2024 Jan; 15(1):344-354. PubMed ID: 38283232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of 4-cyclopropyl-3-(2-((1-cyclopropyl-1
    Wang Q; Tang B; Sun D; Dong Y; Ji Y; Shi H; Zhou L; Yang Y; Luo M; Tan Q; Chen L; Dong Y; Li C; Xie R; Zang Y; Shen J; Xiong B; Li J; Chen D
    Acta Pharm Sin B; 2022 Apr; 12(4):1943-1962. PubMed ID: 35847490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel insights on the molecular mechanism of action of the anti-angiogenic pyrazolyl-urea GeGe-3 by functional proteomics.
    Morretta E; Belvedere R; Petrella A; Spallarossa A; Rapetti F; Bruno O; Brullo C; Monti MC
    Bioorg Chem; 2021 Oct; 115():105168. PubMed ID: 34284173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of MK-8318, a Potent and Selective CRTh2 Receptor Antagonist for the Treatment of Asthma.
    Huang X; Brubaker J; Zhou W; Biju PJ; Xiao L; Shao N; Huang Y; Dong L; Liu Z; Bitar R; Buevich A; Jung J; Peterson SL; Butcher JW; Close J; Martinez M; MacCoss RN; Zhang H; Crawford S; McCormick KD; Aslanian R; Nargund R; Correll C; Gervais F; Qiu H; Yang X; Garlisi C; Rindgen D; Maloney KM; Siliphaivanh P; Palani A
    ACS Med Chem Lett; 2018 Jul; 9(7):679-684. PubMed ID: 30034600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of LY3522348: A Highly Selective and Orally Efficacious Ketohexokinase Inhibitor.
    Durham TB; Hao J; Spinazze P; Stack DR; Toth JL; Massey S; Mbofana CT; Johnston RD; Lineswala JP; Wrobleski A; Mínguez JM; Perez C; Smith DL; Lamar J; Leon R; Corkins C; Durbin J; Tung F; Guo S; Linder RJ; Yumibe N; Wang W; MacKrell J; Antonellis M; Mascaro B
    J Med Chem; 2023 Dec; 66(23):15960-15976. PubMed ID: 37992274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrochemically tuneable hydrogen bonding interactions between a phenyl-urea terminated dendrimer and phenanthrenequinone.
    Cooke G; Sindelar V; Rotello VM
    Chem Commun (Camb); 2003 Mar; (6):752-3. PubMed ID: 12703806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PI(4,5)P
    Rosenhouse-Dantsker A; Gazgalis D; Logothetis DE
    Adv Exp Med Biol; 2023; 1422():3-59. PubMed ID: 36988876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.